Nuzenio

Biomarker Phase

Biomarker Phase news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 4 publisher sources 100/100 entity strength

Latest news

ProMIS Neurosciences Reports Positive 6-Month Interim Safety and Biomarker Results for PMN310 in Phase 1b Alzheimer’s Trial - Quiver QuantitativeQuiver Quantitative · Tue, 28 Jul 2026 10:13:00 GMT ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 10:00:00 GMT Positive Safety and Biomarker Phase 1b Results for PMN310 Mild Cognitive Impairment and Alzheimer Disease - Psychiatric TimesPsychiatric Times · Tue, 28 Jul 2026 07:00:00 GMT Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Tue, 28 Jul 2026 10:13:00 GMTProMIS Neurosciences Reports Positive 6-Month Interim Safety and Biomarker Results for PMN310 in Phase 1b Alzheimer’s Trial - Quiver Quantitative

Tue, 28 Jul 2026 10:00:00 GMTProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial - GlobeNewswire

Tue, 28 Jul 2026 07:00:00 GMTPositive Safety and Biomarker Phase 1b Results for PMN310 Mild Cognitive Impairment and Alzheimer Disease - Psychiatric Times

Tue, 28 Jul 2026 07:00:00 GMTLantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Month Interim Safety4 live mentions Alzheimer4 live mentions Trial3 live mentions ProMIS Neurosciences Reports2 live mentions Biomarker Results2 live mentions Phase2 live mentions Biomarker Data2 live mentions PRECISE2 live mentions AD Phase2 live mentions Results2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Biomarker Phase.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.